EUCTR2006-002935-25-IT进行中（未招募）不适用
multicenter phase II study to evaluate palonosetron +desametasone in the prevention of nausea and vomiting in patientes resected for colon cancer and treated with moderate emetogenus chemotherapy. - paol.+desam. in the prevention of nausea and vomiting
GOIM GRUPPO ONCOLOGICO MERIDIONALE0 个研究点开始时间: 2007年7月2日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •radically resected colorectal cancer patients(stage III).
- •adjuvant treatment with folfox-4 schedule
- •age: > 18 years
- •performance status <1
- •written informated consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •chemotherapy with schedule different from folfox-4
- •previous antiemetic treatments
- •previous treatment with palonosetron
- •lacting or pregnat women
- •planned treatment with radiotherapy with 30 days before the strat of the stady
- •clinical evidence of bowel obstruction, serious infections, serious mucosites.
研究者
相似试验
已完成
2 期
Multicenter Phase II Clinical Study of the research on optimal assessments and treatment strategy of nilotinib in newly diagnosed chronic myelogenous leukemia patients in the chronic phase (CML-CP) based on early achievement of complete molecular response (CMR); N-roadChronic Myelogenous LeukemiaJPRN-UMIN000008565Cooperative study between Jikei University Kashiwa Hospital and Shimousa Hematology Study Group50
未知
2 期
A phase 2 multicenter clinical study evaluating the safety and efficacy of Nilotinib in patients with Imatinib- resistant/intolerant CML in chronic phaseChronic myelogenous leukemiaJPRN-UMIN000001927Tokyo STI Study Group50
尚未招募
2 期
Gene Xpert XDR-TB Kit EvaluatioCTRI/2019/07/020139Foundation for Innovative New Diagnostics India
进行中（未招募）
不适用
A multicenter phase II clinical trial assessing the efficacy of the combination of lapatinib and capecitabine in patients with non pretreated brain metastasis from HER2 positive breast cancer. - LANDSCAPEEUCTR2008-001084-10-FRFNCLCC
招募中
2 期
A multicenter phase II study to evaluate the efficacy and safety of fixed-duration sequential treatment combined with novel agents and autologous stem cell transplantation for newly diagnosed elderly multiple myeloma. -JSCT EMM21Multiple myelomaJPRN-jRCTs071210084Kikushige Yoshikane75